Effects of Tirofiban Maintenance Duration on Myocardial Perfusion Defect Severity in Anterior Myocardial Infarction.

CONCLUSION: The use of tirofiban, when administered at a high bolus dose and maintained for 48 h, was safe and significantly reduced perfusion defect severity in patients with anterior STEMI presenting early after symptom onset and undergoing primary PCI. PMID: 24057341 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24057341?dopt=Abstract

Source: Advances in Therapy - September 21, 2013 Category: Drugs & Pharmacology Authors: Tas MH, Simsek Z, Ayan A, Aksu U, Demirelli S, Koza Y, Lazoglu Z, Seven B, Senocak H Tags: Adv Ther Source Type: research